Key facts
as of Sep 2026- Aledade’s last known valuation is $3.5B (Jun 2023).
- It has raised $1.2B across 8 recorded rounds; the latest was Later Stage VC (Series F) ($260.0M) in Jun 2023.
- Notable investors include Lightspeed Venture Partners, Fidelity Management & Research Company, GV, Tiger Global Management, Headline — 22 tracked in total.
- 4 institutional filers report fund marks on Aledade across 65 filings.
- Aledade has filed 11 Form Ds with the SEC since 2014, most recently Jun 2023 ($260.0M sold to 11 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 8 rounds
- ·The complete investor list — 22 names
- ·Watchlist + deal alerts for Aledade
Recorded secondary trades
No secondary trades in Aledade shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
4 filers · latest Jun 20264 SEC-registered funds reported 65 fair-value marks on Aledade between Apr 2025 and Jun 2026. Filer-level marks and implied $/share are available to Pro members.
Funding rounds
8 roundsAbout Aledade
Operator of a health technology platform intended to access integrated data from across the care continuum quickly. The company's platform is a network of independent primary care, its data, personal coaching, user-friendly workflows, health policy expertise, strong payer relationships, and integrated services enable primary care organizations to succeed financially by keeping people healthy, provide comprehensive insights to identify high-priority action items, including risk suggestions, preventive care opportunities, and recent hospital events, enabling physicians to deliver personalized and on-the-ground care to their patients while reducing overall costs.
- Industry
- Enterprise Systems (Healthcare)
- Sector
- Healthcare
- HQ
- Bethesda, MD, United States
- Founded
- 2014
- Employees
- 1,803
- Website
- aledade.com/
- Ownership
- Privately Held (backing)